Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
NLRP3 Inflammasome and MS/EAE.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Sexual disparities in the incidence and course of MS.
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Multiple sclerosis severity score in a cohort of Moroccan patients.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »